Abstract B109: Results from colorectal cancer and clinical trials health education in racially/ethnically diverse populations

Abstract Introduction: The University of California, San Francisco (UCSF), a National Cancer Institute (NCI) designated comprehensive cancer center implemented NCI’s Colorectal cancer (CRC) and Clinical Trials (CT) Education Initiative to foster awareness, knowledge and intent to uptake CRC screening or participate in CT. Racial/ethnic groups have higher death rates and shorter survival rates for most cancers and face additional disparities and inequities. CRC is the third most commonly diagnosed cancer. CRC screening reduces incidence and mortality, however, it is underutilized. CT are studies that evaluate methods to understand prevent, find and treat cancer plus assess safety 54 average age; 53% African American, 0.3% American Indian, 23% Asian, 13% Latino, 4% Pacific Islander, 3% White 51 average age; 64% African American, 1.2% American Indian, 10% Asian, 17% Latino, 2% Pacific Islander, 4% White 78% importance of people of color CT participation; 48% intent to join a CT and 70% talk to family/friends about joining a CT. Conclusion: CRC and CT education demonstrated efficacy in increasing awareness and knowledge and advanced intent to get colorectal cancer screening and enroll in clinical trials. Citation Format: Michelle Moseley, Eva Pardo, Kim Rhoads, Ghila Andemeskel, Nanci Bocanegra, Tontantzin Rodriguez, Yushan Zhang. Results from colorectal cancer and clinical trials health education in racially/ethnically diverse populations abstract. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B109.